Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premixed human insulin combined with sulfonylureas in type 2 diabetes
ChiCTR-TRC-14004751Phase 4Completed
- Sponsor
- Tongji University
- Start
- Jul 2014
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of Insulin human regular + insulin isophane, glipizide, gliclazide and glimepiride in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Tongji University. Primary endpoints: fasting blood glucose, postprandial blood glucose and 1 more. Started Jul 2014; status: completed.
02
Drugs
Insulin human regular + insulin isophaneglipizidegliclazideglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-14004751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004751.